Our annual survey highlights how immune-oncology and screens based on the application of cutting-edge omics technologies are providing a launchpad for a succession of startups interrogating biology across biomedicine.
Subscribe to Journal
Get full journal access for 1 year
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Garber, K. Natural killer cells blaze into immuno-oncology. Nat. Biotechnol. 34, 219–220 (2016).
Ardolino, M. et al. Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. J. Clin. Invest. 124, 4781–4794 (2014).
Deng, W. et al. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection. Science 348, 136–139 (2015).
Thompson, T.W. et al. Endothelial cells express NKG2D ligands and desensitize antitumor NK responses. eLife 6, e30881 (2017).
Matthews, M.L. et al. Chemoproteomic profiling and discovery of protein electrophiles in human cells. Nat. Chem. 9, 234–243 (2017).
Perni, M. et al. A natural product inhibits the initiation of a-synuclein aggregation and suppresses its toxicity. Proc. Natl. Acad. Sci. USA 114, E1009–E1017 (2017).
Robotta, M., Cattani, J., Martins, J.C., Subramaniam, V. & Drescher, M. Alpha-synuclein disease mutations are structurally defective and locally affect membrane binding. J. Am. Chem. Soc. 139, 4254–4257 (2017).
Svensson, E. et al. Vagotomy and subsequent risk of Parkinson's disease. Ann. Neurol. 78, 522–529 (2015).
Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547–551 (2011).
Chong, J.J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273–277 (2014).
Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388–391 (2016).
Adler, A.S. et al. Rare, high-affinity mouse anti-PD-1 antibodies that function in checkpoint blockade, discovered using microfluidics and molecular genomics. MAbs 9, 1270–1281 (2017).
Adler, A.S. et al. Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics. MAbs 9, 1282–1296 (2017).
Sheridan, C. Recasting natural product research. Nat. Biotechnol. 30, 385–387 (2012).
Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515–1526 (2015).
Mateos-Gomez, P.A. et al. Mammalian polymerase q promotes alternative NHEJ and suppresses recombination. Nature 518, 254–257 (2015).
Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917–921 (2005).
Zhou, Y. et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509, 487–491 (2014).
Zhu, S. et al. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat. Biotechnol. 34, 1279–1286 (2016).
Hartwell, L.H., Szankasi, P., Roberts, C.J., Murray, A.W. & Friend, S.H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064–1068 (1997).
Friend, S.H. & Oliff, A. Emerging uses for genomic information in drug discovery. N. Engl. J. Med. 338, 125–126 (1998).
Brockmann, M. et al. Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling. Nature 546, 307–311 (2017).
Carette, J.E. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326, 1231–1235 (2009).
Chen, R. et al. Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases. Nat. Biotechnol. 34, 531–538 (2016).
About this article
Cite this article
Branca, M., Garber, K. & DeFrancesco, L. Nature Biotechnology's academic spinouts of 2017. Nat Biotechnol 36, 297–306 (2018). https://doi.org/10.1038/nbt.4121
Nanoparticles-mediated Brain Imaging and Disease Prognosis by Conventional as well as Modern Modal Imaging Techniques: a Comparison
Current Pharmaceutical Design (2019)